Cefazolin Injection, Powder, For Solution
Product Images NDC 0404-9835

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cefazolin (NDC 0404-9835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of cefazolin, the active ingredient in CEFAZOLIN injection powder for solution, showing the molecular arrangement including imidazole and beta-lactam rings with sulfur and sodium components.*

FDA Label Image

Image1.jpg (Image1)

A dosage table listing various infection types treated with Cefazolin Injection. It shows corresponding dose ranges and dosing frequencies for conditions including moderate to severe infections, mild gram-positive infections, uncomplicated urinary tract infections, pneumococcal pneumonia, and severe life-threatening infections such as endocarditis and septicemia.*

FDA Label Image

Image2.jpg (Image2)

A pediatric dosage guide table for cefazolin injection powder for solution, presenting dosing information by weight (lbs and kg) for two dosage regimens (25 mg/kg/day and 50 mg/kg/day), each divided into 3 or 4 doses. The table includes approximate single doses in mg and the volume in mL required with specific drug dilutions (125 mg/mL and 225 mg/mL).*

FDA Label Image

Image3.jpg (Image3)

A table showing the relationship between vial size, amount of diluent, approximate concentration, and approximate available volume for cefazolin injection powder. It lists data for 500 mg and 1 gram vial sizes with respective diluent volumes, concentrations, and solution volumes after reconstitution.*

FDA Label Image

Image4.jpg (Image4)

A table listing Cefazolin for Injection, USP with vial sizes, packaging, and NDC numbers. It shows 500 mg and 1 gram strengths in 10 mL vials, each packaged in cartons of 25 vials, with corresponding NDC codes for each strength.*

FDA Label Image

Image5.jpg (Image5)

A data table listing cefazolin for injection, USP with vial sizes of 100 mL. It shows packaging as cartons of 10 vials for 10 grams and 20 grams strengths, including their respective NDC numbers.*

FDA Label Image

Image6.jpg (Image6)

This text panel provides manufacturing and distribution information for a pharmaceutical product. It states the product is manufactured by Hikma Farmacêutica (Portugal) S.A., located in Terrugem SNT, Portugal, and distributed by West-Ward, a Hikma Company based in Eatontown, NJ, USA. The panel also includes a revision date of September 2018 and a reference code P1N001-WES/7.*

FDA Label Image

Label1.jpg (Label1)

CEFAZOLIN 500 mg injection vial label. The label states the vial contains sterile cefazolin sodium equivalent to 500 mg cefazolin with 24 mg sodium content. It includes storage instructions to protect from light and store at controlled room temperature. The label shows the NDC 0404-9835-99, manufacturer Henry Schein Inc. at Bastian, VA, and has placeholders for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.